12th Annual Biosimilars Summit
January 24 - 25, 2017 - Alexandria, VA
With the first four U.S. biosimilars approved and many more in the FDA pipeline, it is critical that pharmaceutical companies develop strategies at a business operations level to comply with evolving regulations, mitigate risk and execute long-term decisions to prepare for success. At CBI’s 12th Biosimilars Summit, you’ll gain insights from industry experts on the tools and strategies needed to prepare for the impending changes impacting all elements of the healthcare industry
This website uses cookies to ensure you get the best experience on our website. Learn more